Peptide therapy should only be used under medical supervision
The compound is sometimes designated PL 14736, PLD-116, or BPC 15 in the research literature, depending on the formulation and trial context
Potential risks include growth hormone's counter-regulatory effects on glucose metabolism that may oppose tirzepatide's benefits, additive gastrointestinal symptoms, and growth hormone-related adverse effects such as edema and joint pain
Factors affecting lyophilized storage duration include initial purity, vial seal integrity, and specific amino acid sequence
Recent research has also explored its role in skin health and hydration
Codeage's and Quicksilver's teams were excellent in their own rights, providing responses within five and 90 minutes, respectively